Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
909,540
-
Shares change
-
+310,590
-
Total reported value, excl. options
-
$21,474,985
-
Value change
-
+$7,409,653
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$23.24
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2017
9 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2017.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 909,540 shares
.
Largest 10 shareholders include Parametric Portfolio Associates LLC (803,435 shares), World Asset Management Inc (98,492 shares), QUADRANT CAPITAL GROUP LLC (5,126 shares), Hexavest Inc. (1,134 shares), GLENMEDE TRUST CO NA (830 shares), Geneos Wealth Management Inc. (364 shares), MASSMUTUAL TRUST CO FSB/ADV (84 shares), FTB Advisors, Inc. (75 shares), AMERIPRISE FINANCIAL INC (0 shares), and GLENMEDE TRUST CO NA (114 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.